The global DNA Sequencing market reached a value of about USD 9.1 billion in 2021. The industry is projected to grow at a CAGR of around 22% in the forecast period of 2022-2027 to reach a value of about USD 30 billion by 2027.
The global DNA Sequencing industry report gives a comprehensive analysis of the industry, including key segments, trends, drivers, restraints, the competitive landscape, and other essential market aspects. The wide range of technology applications is driving the market's development. North America is the highest category spender by region, driving the demand for the DNA Sequencing industry.
Sequencing DNA entails establishing the order of the four chemical building units that make up the DNA molecule (adenine, thymine, cytosine, and guanine, or "bases"). Rapid DNA sequencing devices have substantially developed biological and medical study and breakthroughs. The sequence informs scientists about the genetic information contained by a particular DNA segment.
The DNA Sequencing industry report comprises segments by end-users (Academics & Research Institutes, Pharma & Biotech and Hospitals & Clinics), application (Clinical and Non-Clinical), and region (North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America).
North America holds the largest share in the industry due to the increased financing and support efforts by government and non-government groups, particularly in the United States. The fundamental driving forces for DNA sequencing in the nation are the rising usage of modern technology and favourable government backing and legislation. Furthermore, the market is expanding due to the ongoing technical breakthroughs by significant companies, effective R&D expenditure, and the presence of technologically sophisticated healthcare infrastructure.
The market is being driven by DNA sequencing in Diagnostics, customised medicine, biomarkers, forensics, reproductive health, and other applications. It has simplified nucleotide analysis and has mostly superseded traditional genomics technologies such as microarray, genotyping, and others furthering its growth. In addition, the employment of technology in clinical research for the development of cancer diagnoses and therapies is likely to provide new opportunities. The next-generation sequencing (NGS) technology has proved its ability to identify and characterise clinically relevant genetic variations across several genes at an unprecedented speed in a single test, demonstrating its capability as a high-throughput and cheap technique. As a result, it is gaining traction in the industry. The technology's properties, such as speed, affordability, accuracy, efficient replacement of conventional technologies, and drug discovery applications requiring NGS technology, drive the market demand.
The global DNA Sequencing industry report by Procurement Resource gives an in-depth analysis of the best buying practices followed by major global DNA Sequencing regions, such as engagement models, contract terms, and buyer and supplier negotiation levers, among others.
The process involves various methods; the Sanger method is a traditional DNA sequencing method that prevents the addition of another nucleotide by using fluorescent ddNTPs (dideoxynucleotides, N = A, T, G, or C). Secondly, massively parallel sequencing, also known as next-generation sequencing, may establish the order of millions of pieces simultaneously. NGS is a type of short-read sequencing that involves building a small fragment library, deep sequencing, raw data pre-processing, DNA sequence alignment, assembly, annotation, and downstream analysis. Also, Third-generation sequencing or long-read sequencing incorporating PacBio SMRT sequencing and Oxford nanopore sequencing can look at billions of DNA and RNA templates at once and find varied methylations without bias. Long-read techniques can detect more variants, including those that short-read sequencing alone cannot detect.
The industry is witnessing growth due to the various technological developments in medicine, resulting in the creation of customised treatment. Next-generation sequencing has a wide range of applications in personalised medicine. Furthermore, promising potential in biomarkers, cancer, diagnostics, personalised medicine, forensics, and reproductive health is expected to fuel worldwide growth. Moreover, Platforms like Illumina/ Solexa, ABI/ SOLiD, 454/Roche, and Helicos have opened up new possibilities for high-throughput functional genomics research. Furthermore, biologists and informatics professionals have been concentrating on creating better genomes, which have been made feasible by newer sequencing technology, unique ways for finding sequences on chromosomes, and enhanced DNA sequencing software. Other market expansion factors include increased partnerships, collaborations, rise in DNA sequencing technological developments, expanded use in clinical diagnostics and drug discovery, and growing R&D spending.
The regional markets for the industry can be divided into North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The worldwide DNA sequencing business is fiercely competitive, with just a few large competitors remaining. These players are attempting to meet expanding customer demand by investing significantly in manufacturing, distribution, and comprehensive quality control to expand their product lines.
1. Executive Summary
2. DNA Sequencing Market Snapshot
2.1. DNA Sequencing Market Outlook
2.2. DNA Sequencing Industry Analysis by End Users
2.2.1. Academics & Research Institutes
2.2.2. Pharma & Biotech
2.2.3. Hospitals & Clinics
2.3. DNA Sequencing Industry Analysis by Application
2.4. Region Overview
2.4.1. North America
2.4.2. Asia Pacific
2.4.4. Latin America
2.4.5. Middle East and Africa
3. Impact of Recent Events
4. DNA Sequencing Value Chain Analysis
5. DNA Sequencing Production Process
6. Trade Analysis
7. Major Risk Factors in Sourcing
8. DNA Sequencing Cost Structure
9. DNA Sequencing Price Analysis
10. Key Demand Indicator Analysis
11. Key Price Indicator Analysis
12. DNA Sequencing Market Dynamics
12.1. Drivers & Constraints
12.2. Industry Events
12.3. Innovations & Trends
12.4. Swot Analysis
12.5. Porter’s Five Forces
12.5.1. Buyer Power
12.5.2. Supplier Power
12.5.3. Threat of New Entrants
12.5.4. Threat of Substitutes
12.5.5. Industry Rivalry
13. Industry Best Practices
13.1. Sourcing Strategy
13.2. Procurement Model
13.3. Contract Structure
13.4. Negotiation Levers
13.5. Pricing Model
13.6. Key Factors Influencing the Quotation
14. Key Supplier Analysis
14.1. Charles River Laboratories International, Inc.
14.2. Labcorp Drug Development
14.3. Eurofins GSC Lux SARL
14.4. Agilent Technologies, Inc.
14.5. Thermo Fisher Scientific Inc.
The global DNA Sequencing market size was valued at USD 9.1 billion in 2021.
As per the end-user provided, the Academics & Research institutes segment is anticipated to lead the market between the period 2022 – 2027.
The significant demand for next-generation sequencing (NGS) technology is one of the essential drivers of the DNA Sequencing market growth.
Charles River Laboratories International, Inc., Labcorp Drug Development, Eurofins GSC Lux SARL, Agilent Technologies, Inc. and Thermo Fisher Scientific Inc. are some of key players in the market.
The North American region of the DNA Sequencing industry holds a significant share in the market.
The global DNA Sequencing market attained a value of USD 9.1 billion in 2021, driven by the use of DNA sequencing in Diagnostics, customised medicine, biomarkers, forensics, reproductive health, and other applications. In addition, the next-generation sequencing (NGS) technology's properties such as speed, affordability, accuracy, efficient replacement of conventional technologies, and drug discovery applications are boosting the market demand. Aided by the growing technological advancements in the field of medicine, promising potential in biomarkers, cancer, diagnostics, personalised treatment, forensics, and reproductive health is propelling the industry's expansion. Also, owing to an increase in partnerships and collaborations rise in technological developments in DNA sequencing, expanding use in clinical diagnostics and drug discovery, and growing R&D spending, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 22%. The market is projected to reach USD 30 billion by 2027. Some of the leading players in the industry are Charles River Laboratories International, Inc., Labcorp Drug Development, Eurofins GSC Lux SARL, Agilent Technologies, Inc. and Thermo Fisher Scientific Inc.
Procurement Resources' detailed research approach explores deep into the industry, encompassing the macro and micro aspects of the industry. Its team of experts uses a combination of cutting-edge analytical tools and their expertise, thus, delivering its customers with market insights that are accurate and actionable and help them remain ahead of their competition.
At Procurement Resource our analysts are selected after they are assessed thoroughly on having required qualities so that they can work effectively and productively and are able to execute projects based on the expectations shared by our clients. Our team is hence, technically exceptional, strategic, pragmatic, well experienced and competent.
We understand the cruciality of high-quality assessments that are important for our clients to take timely decisions and plan strategically. We have been continuously upgrading our tools and resources over the past years to become useful partners for our clientele. Our research methods are supported by most recent technology, our trusted and verified databases that are modified as per the needs help us serve our clients effectively every time and puts them ahead of their competitors.
Our team provides a detailed, high quality and deeply researched evaluations in competitive prices, that are unmatchable, and demonstrates our understanding of our client’s resource composition. These reports support our clientele make important procurement and supply chains choices that further helps them to place themselves ahead of their counterparts. We also offer attractive discounts or rebates on our forth coming reports.
Our vision is to enable our clients with superior quality market assessment and actionable evaluations to assist them with taking timely and right decisions. We are always ready to deliver our clients with maximum results by delivering them with customised suggestions to meet their exact needs within the specified timeline and help them understand the market dynamics in a better way.
Email Delivery Price: $ 999.00
The global Artificial Intelligence market reached a value of about USD 192 Billion in 2021. The industry is projected to grow at a CAGR of around 23% in the forecast period of 2022-2027 to reach a value of about USD 664.86 Billion by 2027.Read More
Email Delivery Price: $ 999.00
The global nutmeg market reached a value of about 130 thousand tonnes in 2021. The industry is further expected to grow at a CAGR of about 6% in the forecast period of 2022-2027 to reach a value of around 180 thousand tonnes by 2027.Read More
Email Delivery Price: $ 999.00
The global HEOR market reached a value of about USD 1364.3 million in 2021. The industry is further expected to grow at a CAGR of about 12.81% in the forecast period of 2022-2027 to reach a value of around USD 2779.2 million by 2027.Read More